跳至主要内容
临床试验/ITMCTR2100004300
ITMCTR2100004300招募中1 期

Trigger point dry needling in the treatment of postherpetic neuralgia: a prospective, randomized controlled study

The First Affiliated Hospital of Jinan University0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 99(—)
性别
All

入选标准

  • (1) The diagnosis of postherpetic neuralgia was based on the Chinese Expert Consensus on the Diagnosis and Treatment of postherpetic neuralgia.
  • (2) Visual analogue scale(VAS) of pain score above 4.
  • (3) No contraindications or intolerable adverse reactions to neuropathic pain drugs, such drugs include: pregabalin, amitriptyline, opioids (tramadol, morphine, oxycodone, etc.).
  • (4) Premenopausal women are willing to confirm birth control measures during the trial.
  • (5) No other treatment will be given during the trial.
  • (6) Have normal comprehension and expression ability.

排除标准

  • (1) Patients with other severe chronic pain.
  • (2) Initiate additional treatment during the trial.
  • (3) The patient is pregnant or nursing.
  • (4) Patients with drug or alcohol dependence.
  • (5) Mental illness that affects patients' judgment or interferes with the conduct of the trial.
  • (6) Unwilling to accept the review or unable to understand the scale measurement.
  • (7) Patients with nausea tumor (except patients without recurrence 6 months after radical surgery).
  • (8) Patients with abnormal coagulation function.
  • (9) Patients with acute thrombotic events: ischemic stroke, myocardial infarction, pulmonary embolism, deep venous thrombosis, etc.
  • (10) Unstable angina pectoris.
  • (11) Renal insufficiency (serum creatinine 1.5 times higher than the normal high value).
  • (12) The Investigator considers that there are any conditions that could pose a medical risk or affect the outcome of the trial.
  • (13) Participate in other medical trials during the study period.

研究者

发起方
The First Affiliated Hospital of Jinan University

相似试验